| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $83.2M | +16.8% |
| SG&A Expense | $16.0M | +4.9% |
| Operating Income | -$99.2M | +17.0% |
| Net Income | -$93.6M | +22.3% |
| EPS (Basic) | -$2.11 | +44.2% |
| EPS (Diluted) | -$2.11 | +44.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.7M | -56.3% |
| Current Assets | $52.5M | -58.3% |
| Total Assets | $54.3M | -57.5% |
| Current Liabilities | $24.7M | +89.1% |
| Total Liabilities | $25.4M | +80.3% |
| Stockholders' Equity | $28.9M | -74.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.8M | -8.7% |
| Capital Expenditures | $334K | +198.2% |
| Investing Cash Flow | $9.5M | +197.1% |
| Financing Cash Flow | $1.0M | -98.9% |
| Free Cash Flow | -$71.2M | -9.1% |